computational biologist @grailbio, formerly @MITCSBPhD grad student @daspliceisright lab. Native Minnesotan, played tennis, flute @harvardband in former life.
@checks_inc Investing in SCHD is a much better approach for 30/40 years IMO...starting 3.5% yield, qualified dividends, and dividends grow ~10% each year! https://t.co/5a6FKg69SF
@jameslavish Minor correction in the newsletter - you say that the national debt "has doubled every 1.1 years" since 1980...this is not correct - that would be exponential growth!
@GenExDividend Not a big position, but PTON. The way it changed from a positive narrative to a negative one so quickly without much change in the underlying product (users still use/love the product) was surprising, even with the slowing growth IMO.
Our new study shows that data availability statements are not very useful; 1670 (93%) authors who indicated that data are available on request either did not respond or declined to share their data with us. Journal of Clinical Epidemiology: https://t.co/4IT2Dgphl4
@garybembridge@SeabournCruise Would not surprise me…they do have $30 billion in debt that eventually needs to get paid somehow… https://t.co/gVswF1lUDy
@nlarusstone CRAN reviews packages after submission before release and a package with such a name would almost certainly be rejected https://t.co/uOcx05mmuG
I would like everyone in science to read the painful, poignant description of what, exactly, Sabatini did to women under his mentorship. It should make you sick to your stomach. I don't think I could still be in science if I'd faced any of this. https://t.co/vJ5E7NWMEJ